Cambridge Investment Research Advisors
VANI icon

Cambridge Investment Research Advisors’s Vivani Medical VANI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,383
Closed -$52K – 3277
2021
Q3 		$52K Hold
5,383
– – ﹤0.01% 3023
2021
Q2 		$80K Buy
+5,383
New +$104K ﹤0.01% 2996

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cambridge Investment Research Advisors's VANI Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Vivani Medical (VANI) in Q4 2021, closing a stake of 5,383 shares — an estimated $52K sold.

Cambridge Investment Research Advisors first reported a position in VANI in Q2 2021 and held it in 2 quarters. The position peaked at $80K in Q2 2021. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2021.

  • Cambridge Investment Research Advisors reported no remaining Vivani Medical position as of Q4 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,383 Vivani Medical shares in Q4 2021, an estimated $52K.
  • Cambridge Investment Research Advisors first reported a position in Vivani Medical in Q2 2021 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Vivani Medical position peaked at $80K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.